Skip to main content
. 2021 Aug 19;9(8):1048. doi: 10.3390/biomedicines9081048

Figure 2.

Figure 2

Overview of high-potential future therapeutic approaches for sarcomas with simple genomes or sarcomas with immunologically “cold” or excluded TME.